Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2

2(40.0%)

Phase 4

1(20.0%)

Phase 1

1(20.0%)

N/A

1(20.0%)

5Total

Phase 2(2)

Phase 4(1)

Phase 1(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06378190Phase 1Recruiting

Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology

Role: collaborator

NCT07437482Not Yet Recruiting

Cancer Literacy Education and Awareness Resources for Prostate Care

Role: collaborator

NCT07036783Not Yet Recruiting

3D Decision Support Tool for Brain Tumour Surgery Development and Validation: Observational Study

Role: lead

NCT04241978Not ApplicableCompleted

Development and Evaluation of a Web Based Decision Aid for Patients With Hip Osteoarthritis

Role: collaborator

NCT04936282Phase 4Unknown

Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients (TRAINING)

Role: lead

NCT03660657Phase 2Terminated

Ozone Therapy in Refractory Ischemic Heart Disease.

Role: collaborator

NCT03196388Phase 2Unknown

Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate Cancer

Role: lead

All 7 trials loaded